What are the recommended eye drops for treating allergy conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Eye Drops for Allergic Conjunctivitis

Dual-action agents (combined antihistamine and mast cell stabilizer) are the most effective first-line treatment for allergic conjunctivitis due to their rapid onset of action and ability to both treat acute symptoms and prevent future episodes. 1

First-Line Treatment Options

  • Dual-action agents such as olopatadine, ketotifen, epinastine, and azelastine provide both immediate relief and ongoing prevention of symptoms 2, 1
  • Olopatadine 0.1% is administered as 1 drop in the affected eye(s) twice daily, every 6-8 hours, for patients 2 years and older 3
  • Ketotifen is administered as 1 drop in the affected eye(s) twice daily, every 8-12 hours, for patients 3 years and older 4
  • High-concentration olopatadine 0.77% has shown longer duration of action and better efficacy for ocular itching compared to other agents 5
  • Cold compresses and irrigation with saline solution or artificial tears are recommended for mild symptoms 2, 1

Second-Line Treatment Options

  • Mast cell stabilizers (cromolyn, lodoxamide, nedocromil, pemirolast) are better for prophylactic or longer-term treatment due to their slow onset of action (several days) 2, 1
  • Cromolyn sodium is administered as 1-2 drops in each eye 4-6 times daily at regular intervals 6
  • Symptomatic response to cromolyn therapy may take a few days, with some patients requiring up to six weeks of treatment 6
  • Topical NSAIDs such as ketorolac are indicated for temporary relief of ocular itching caused by seasonal allergic conjunctivitis 2

Third-Line Treatment Options

  • For severe cases or acute exacerbations, a brief course (1-2 weeks) of topical corticosteroids with a low side effect profile, such as loteprednol etabonate, may be added to the regimen 2, 1
  • Topical corticosteroids should be used with caution due to risks of increased intraocular pressure, cataract formation, and secondary infections 2, 1
  • Monitoring for increased IOP and cataract formation is necessary when using topical corticosteroids 1

Comparative Efficacy

  • In head-to-head studies, patients preferred olopatadine over ketotifen when evaluating both efficacy and comfort 7
  • Epinastine 0.05% has shown superiority to placebo and equal or better efficacy than olopatadine 0.1% for ocular itch and conjunctival hyperemia 5
  • Olopatadine used adjunctively with oral antihistamines (e.g., loratadine) provides greater relief of ocular itching and redness than oral antihistamines alone 8

Important Considerations and Precautions

  • Prolonged use of ocular vasoconstrictors can lead to rebound hyperemia (conjunctivitis medicamentosa) 2, 1
  • Oral antihistamines may worsen dry eye syndrome and impair the tear film's protective barrier 2, 1
  • Refrigerated preservative-free artificial tears can provide additional relief by diluting allergens and inflammatory mediators 1
  • Punctal plugs should be avoided in allergic conjunctivitis as they prevent flushing of allergens and inflammatory mediators from the ocular surface 2
  • When using multiple ophthalmic products, wait at least 5 minutes between each product 3

Special Populations

  • For vernal keratoconjunctivitis or atopic conjunctivitis, topical cyclosporine 0.05% has been shown to be effective and may allow for reduced use of topical steroids 2
  • For severe or refractory cases, consultation with an allergist or ophthalmologist may be beneficial 2
  • Children under age 2 (for olopatadine) or under age 3 (for ketotifen) should be treated only after consultation with a doctor 3, 4

References

Guideline

Treatment of Allergic Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.